Intriguing hepatoprotective effects of sucrose on hepatocellular carcinoma pathogenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Intriguing hepatoprotective effects of sucrose on hepatocellular carcinoma pathogenesis ; volume:14 ; number:1 ; day:10 ; month:10 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (10.10.2024), 1-11, 12.2024
- Urheber
-
Aguirre-Maldonado, Isaac
Herrera-López, Ema Elvira
López-Zenteno, Fernando
Ramírez-Nava, Julio César
López-Hernández, Norma Arely
Arellanes-Robledo, Jaime
del Pozo-Yauner, Luis
García-Román, Rebeca
Montero, Hilda
Alexander-Aguilera, Alfonso
Noyola-Díaz, Juana Martha
Camacho, Javier
Pérez-Carreón, Julio Isael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-74991-4
- URN
-
urn:nbn:de:101:1-2412272106502.744802366552
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aguirre-Maldonado, Isaac
- Herrera-López, Ema Elvira
- López-Zenteno, Fernando
- Ramírez-Nava, Julio César
- López-Hernández, Norma Arely
- Arellanes-Robledo, Jaime
- del Pozo-Yauner, Luis
- García-Román, Rebeca
- Montero, Hilda
- Alexander-Aguilera, Alfonso
- Noyola-Díaz, Juana Martha
- Camacho, Javier
- Pérez-Carreón, Julio Isael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pathogenesis of human hepatocellular carcinoma
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression
Hepatocellular Carcinoma
Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
Subclinical hepatocellular carcinoma
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity
Biomarker in Hepatocellular Carcinoma
Epigenetics of hepatocellular carcinoma
Chemoembolization of Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression
Hepatocellular Carcinoma
Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
Subclinical hepatocellular carcinoma
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity
Biomarker in Hepatocellular Carcinoma
Epigenetics of hepatocellular carcinoma
Chemoembolization of Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
Role of immunity in pathogenesis and treatment of hepatocellular carcinoma
EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression
Hepatocellular Carcinoma
Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
Subclinical hepatocellular carcinoma
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity
Biomarker in Hepatocellular Carcinoma
Epigenetics of hepatocellular carcinoma